NCT06196879Phase 2Completed

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

Study sponsor: Upstream Bio Inc. · UPB

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2025-12-16Actual
Enrollment · participants479Actual
Source updated2026-05-01Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Recruitment status changed

− Before

Active not recruiting

+ After

Completed

Check registry source

· 2 fields changed

Completion date type changed

− Before

Estimated

+ After

Actual

Primary completion date changed

− Before

19 Feb 2026

+ After

16 Dec 2025

Check registry source